N-Desmethyltamoxifen |
Catalog No.GC25662 |
N-Desmethyltamoxifen, the major metabolite of Tamoxifen in humans and a ten-fold more potent protein kinase C (PKC) inhibitor than Tamoxifen, also is a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 31750-48-8
Sample solution is provided at 25 µL, 10mM.
N-Desmethyltamoxifen, the major metabolite of Tamoxifen in humans and a ten-fold more potent protein kinase C (PKC) inhibitor than Tamoxifen, also is a potent regulator of ceramide metabolism in human AML cells, limiting ceramide glycosylation, hydrolysis, and sphingosine phosphorylation.
[1] Vertosick FT Jr, et al. J Neurooncol. 1994;19(2):97-103. [2] Morad SA, et al. Biochim Biophys Acta. 2015 Jul;1851(7):919-28.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *